Verisante Technology Inc. (VRSEF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 35.72 Thousand CAD | -59.55% |
| 2022 | 88.32 Thousand CAD | -39.48% |
| 2021 | 145.94 Thousand CAD | 1101.69% |
| 2020 | 12.14 Thousand CAD | 5.49% |
| 2019 | 11.51 Thousand CAD | -96.46% |
| 2018 | 324.9 Thousand CAD | -0.9% |
| 2017 | 327.85 Thousand CAD | -85.92% |
| 2016 | 2.32 Million CAD | -30.86% |
| 2015 | 3.36 Million CAD | -28.61% |
| 2014 | 4.71 Million CAD | -13.25% |
| 2013 | 5.43 Million CAD | -20.33% |
| 2012 | 6.82 Million CAD | -22.08% |
| 2011 | 8.76 Million CAD | 473.8% |
| 2010 | 1.52 Million CAD | 6.7% |
| 2009 | 1.43 Million CAD | 524.26% |
| 2008 | 229.22 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 14.71 Thousand CAD | -61.16% |
| 2024 Q1 | 37.88 Thousand CAD | 6.03% |
| 2023 Q4 | 35.72 Thousand CAD | -19.64% |
| 2023 Q1 | 69.65 Thousand CAD | -21.14% |
| 2023 Q3 | 44.45 Thousand CAD | -1.21% |
| 2023 FY | 35.72 Thousand CAD | -59.55% |
| 2023 Q2 | 45 Thousand CAD | -35.39% |
| 2022 Q2 | 23.08 Thousand CAD | -4.33% |
| 2022 Q1 | 24.13 Thousand CAD | -83.46% |
| 2022 Q3 | 103.72 Thousand CAD | 349.26% |
| 2022 FY | 88.32 Thousand CAD | -39.48% |
| 2022 Q4 | 88.32 Thousand CAD | -14.84% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | 145.94 Thousand CAD | 1101.69% |
| 2021 Q4 | 145.94 Thousand CAD | 0.0% |
| 2020 FY | 12.14 Thousand CAD | 5.49% |
| 2019 FY | 11.51 Thousand CAD | -96.46% |
| 2018 FY | 324.9 Thousand CAD | -0.9% |
| 2017 Q4 | 327.85 Thousand CAD | -82.59% |
| 2017 Q1 | 2.14 Million CAD | -7.7% |
| 2017 Q2 | 2.01 Million CAD | -6.4% |
| 2017 FY | 327.85 Thousand CAD | -85.92% |
| 2017 Q3 | 1.88 Million CAD | -6.41% |
| 2016 Q1 | 3.11 Million CAD | -7.61% |
| 2016 Q4 | 2.32 Million CAD | -11.52% |
| 2016 Q3 | 2.63 Million CAD | -8.11% |
| 2016 Q2 | 2.86 Million CAD | -7.95% |
| 2016 FY | 2.32 Million CAD | -30.86% |
| 2015 FY | 3.36 Million CAD | -28.61% |
| 2015 Q1 | 4.05 Million CAD | -14.12% |
| 2015 Q2 | 3.94 Million CAD | -2.67% |
| 2015 Q3 | 3.66 Million CAD | -7.0% |
| 2015 Q4 | 3.36 Million CAD | -8.16% |
| 2014 Q1 | 5.15 Million CAD | -5.3% |
| 2014 FY | 4.71 Million CAD | -13.25% |
| 2014 Q3 | 4.68 Million CAD | -8.69% |
| 2014 Q4 | 4.71 Million CAD | 0.73% |
| 2014 Q2 | 5.13 Million CAD | -0.39% |
| 2013 Q3 | 6.11 Million CAD | -8.03% |
| 2013 FY | 5.43 Million CAD | -20.33% |
| 2013 Q4 | 5.43 Million CAD | -11.02% |
| 2013 Q2 | 6.64 Million CAD | -2.7% |
| 2013 Q1 | 6.83 Million CAD | 0.07% |
| 2012 Q4 | 6.82 Million CAD | -6.12% |
| 2012 FY | 6.82 Million CAD | -22.08% |
| 2012 Q1 | 7.96 Million CAD | -9.09% |
| 2012 Q2 | 7.35 Million CAD | -7.62% |
| 2012 Q3 | 7.27 Million CAD | -1.17% |
| 2011 FY | 8.76 Million CAD | 473.8% |
| 2011 Q1 | 2.26 Million CAD | 48.66% |
| 2011 Q2 | 6.63 Million CAD | 192.5% |
| 2011 Q3 | 8.33 Million CAD | 25.51% |
| 2011 Q4 | 8.76 Million CAD | 5.14% |
| 2010 Q1 | 1.22 Million CAD | -14.25% |
| 2010 FY | 1.52 Million CAD | 6.7% |
| 2010 Q4 | 1.52 Million CAD | -4.58% |
| 2010 Q3 | 1.6 Million CAD | 78.72% |
| 2010 Q2 | 895.37 Thousand CAD | -27.02% |
| 2009 Q4 | 1.43 Million CAD | 325.12% |
| 2009 Q3 | 336.59 Thousand CAD | 0.0% |
| 2009 FY | 1.43 Million CAD | 524.26% |
| 2008 FY | 229.22 Thousand CAD | 0.0% |
| 2008 Q4 | 229.22 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AVITA Medical, Inc. | 144.33 Million USD | 99.975% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | 88.693% |
| Össur hf. | 1.39 Billion USD | 99.997% |
| QHSLab, Inc. | 1.68 Million USD | 97.875% |
| Wellstar International, Inc. | 957.89 Thousand USD | 96.27% |
| Össur hf. | 1.39 Billion USD | 99.997% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 4.75 Million USD | 99.249% |
| Aurora Spine Corporation | 11.92 Million USD | 99.7% |
| BrainsWay Ltd. | 62.97 Million USD | 99.943% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 144.38 Thousand USD | 75.255% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 99.968% |
| Vivos Inc. | 1.61 Million USD | 97.781% |
| Kelyniam Global, Inc. | 1.63 Million USD | 97.812% |
| REMSleep Holdings, Inc. | 1.2 Million USD | 97.038% |
| Zecotek Photonics Inc. | 2.57 Million USD | 98.611% |
| Avitar, Inc. | 1.74 Million USD | 97.956% |
| Nanomix Corporation | 982.05 Thousand USD | 96.362% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 99.965% |
| Theraclion SA | 18.66 Million EUR | 99.809% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.76 Million USD | 97.979% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | 95.226% |
| Lombard Medical, Inc. | 67.76 Million USD | 99.947% |
| ALR Technologies Inc. | 193.21 Thousand USD | 81.508% |
| Stratec SE | 529.71 Million USD | 99.993% |
| Vycor Medical, Inc. | 992.29 Thousand USD | 96.399% |
| Heart Tronics, Inc. | 4.04 Million USD | 99.118% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.999% |
| VMS Rehab Systems, Inc. | 4.45 USD | -802798.876% |
| NewCardio, Inc. | 2.85 Million USD | 98.748% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 97.859% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | 95.157% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | 92.161% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | 34.739% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | 80.388% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 99.841% |
| IR-Med Inc. | 999 Thousand USD | 96.424% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 99.826% |
| Polarean Imaging plc | 10.86 Million USD | 99.671% |
| United American Healthcare Corporation | 10.37 Million USD | 99.656% |
| ECGI Holdings, Inc. | 5.2 Million USD | 99.313% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 98.385% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -5.726% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 98.329% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | 95.897% |
| Urologix, Inc. | 5.66 Million USD | 99.37% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 98.415% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 99.824% |
| SS Innovations International, Inc. | 25.47 Million USD | 99.86% |
| Qualis Innovations, Inc. | 2431.00 USD | -1369.724% |
| Smith & Nephew plc | 9.97 Billion USD | 100.0% |
| NIOX Group Plc | 116.47 Million USD | 99.969% |
| Fuse Medical, Inc. | 16.25 Million USD | 99.78% |
| Broncus Holding Corporation | 195.75 Million USD | 99.982% |
| Brain Scientific Inc. | 11.74 Million USD | 99.696% |
| Pressure BioSciences, Inc. | 1.04 Million USD | 96.596% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -24.34% |